Literature DB >> 10951277

Evidence for the existence of a self-regulated enzymatic process within the human stratum corneum -an unexpected role for urocanic acid.

P M Krien1, M Kermici.   

Abstract

The existence of a flux of proton donors from skin (inner part of the forearm) to the electrode was observed in 12 male and female volunteers. This flux was used to collect and identify the ionic species responsible for skin acidity. It was then found that: (i) pK of these proton donors (pK = 6.13 +/- 0.07) was quasi-identical to that of trans-urocanic acid (6.10), and (ii) the amount of urocanic acid present in stratum corneum was sufficient in itself to explain the acidic level as measured with pH meter (R = 0.8484, n = 10, p = 0.00136). As a result, the contribution of other ionic species can be considered as negligible in normal human skin. The data recorded led us to identify three groups (Fast, Medium, and Slow) characterized by different skin surface pH values (low, medium, and close to neutral) and showing a pH gradient in the outer layers of the stratum corneum, or not. Data analysis suggests that these characteristics depend on urocanic acid production rate within the stratum corneum and that this production rate is self-regulated by its urocanic acid content.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951277     DOI: 10.1046/j.1523-1747.2000.00083.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  33 in total

Review 1.  What is the 'true' function of skin?

Authors:  C M Chuong; B J Nickoloff; P M Elias; L A Goldsmith; E Macher; P A Maderson; J P Sundberg; H Tagami; P M Plonka; K Thestrup-Pederson; B A Bernard; J M Schröder; P Dotto; C M Chang; M L Williams; K R Feingold; L E King; A M Kligman; J L Rees; E Christophers
Journal:  Exp Dermatol       Date:  2002-04       Impact factor: 3.960

Review 2.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

3.  Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis.

Authors:  Peter M Elias
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 4.  "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.

Authors:  Peter M Elias; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2008-05       Impact factor: 8.551

Review 5.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 6.  Skin Physiology of the Neonate and Infant: Clinical Implications.

Authors:  Teresa Oranges; Valentina Dini; Marco Romanelli
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-10-01       Impact factor: 4.730

Review 7.  Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

8.  Is the filaggrin-histidine-urocanic acid pathway essential for stratum corneum acidification?

Authors:  Joachim W Fluhr; Peter M Elias; Mao-Qiang Man; Melanie Hupe; Clare Selden; John P Sundberg; Erwin Tschachler; Leopold Eckhart; Theodora M Mauro; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2010-04-08       Impact factor: 8.551

9.  Two-photon fluorescence lifetime imaging of the skin stratum corneum pH gradient.

Authors:  Kerry M Hanson; Martin J Behne; Nicholas P Barry; Theodora M Mauro; Enrico Gratton; Robert M Clegg
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

10.  Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification.

Authors:  Joachim W Fluhr; Mao-Qiang Man; Jean-Pierre Hachem; Debra Crumrine; Theodora M Mauro; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.